Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis

Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis

Background: Inflammatory responses influence the outcome of immunotherapy and tumorigenesis by modulating host immunity. However, systematic inflammatory response assessment models for predicting cancer immunotherapy (CIT) responses and survival across human cancers remain unexplored. Here, we inves...

Full description

Bibliographic Details
Main Authors:	Shuzhao Chen, Mayan Huang, Limei Zhang, Qianqian Huang, Yun Wang, Yang Liang
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	Computational and Structural Biotechnology Journal
Subjects:	Cancer immunotherapy response Inflammatory response Tumor immunity Biomarker
Online Access:	http://www.sciencedirect.com/science/article/pii/S2001037023004762

Similar Items

A tumor-associated endothelial signature score model in immunotherapy and prognosis across pan-cancers
by: Shuzhao Chen, et al.
Published: (2023-08-01)

Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy
by: Yangyang Guo, et al.
Published: (2023-06-01)

Angiogenic Factor-Based Signature Predicts Prognosis and Immunotherapy Response in Non-Small-Cell Lung Cancer
by: Xinpei Gu, et al.
Published: (2022-05-01)

Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis
by: Zewei Tu, et al.
Published: (2022-05-01)

Correlation analysis of disulfidptosis-related gene signatures with clinical prognosis and immunotherapy response in sarcoma
by: Juan Xu, et al.
Published: (2024-03-01)

An integrative pan-cancer bioinformatics analysis of MSRB1 and its association with tumor immune microenvironment, prognosis, and immunotherapy
by: Shanshan Jiang, et al.
Published: (2024-02-01)

Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
by: Anmin Huang, et al.
Published: (2022-09-01)

Development and validation of polyamines metabolism-associated gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma
by: Ning Wang, et al.
Published: (2023-06-01)

The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response
by: Gujie Wu, et al.
Published: (2022-04-01)

Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma
by: Jinfeng Zhu, et al.
Published: (2023-08-01)

Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
by: Zhihao Yao, et al.
Published: (2022-09-01)

A novel pyroptosis-regulated gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma
by: Baozhu Zhang, et al.
Published: (2022-09-01)

Role of DNA repair defects in predicting immunotherapy response
by: Jing Zhang, et al.
Published: (2020-06-01)

Erratum: Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
by: Frontiers Production Office
Published: (2022-12-01)

Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration
by: Fu Y, et al.
Published: (2021-12-01)

Systematic analysis reveals a pan-cancer SNHG family signature predicting prognosis and immunotherapy response
by: Haotian Zheng, et al.
Published: (2023-10-01)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
by: Sheng Yu, et al.
Published: (2023-07-01)

Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy
by: Laura Keller, et al.
Published: (2018-11-01)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
by: Tong Lin, et al.
Published: (2021-10-01)

PTPRO-related CD8+ T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer
by: Hongmei Dong, et al.
Published: (2022-08-01)

Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma
by: Rossella Puglisi, et al.
Published: (2021-06-01)

An individualized stemness‐related signature to predict prognosis and immunotherapy responses for gastric cancer using single‐cell and bulk tissue transcriptomes
by: Linyong Zheng, et al.
Published: (2024-01-01)

Identification of diagnostic signature, molecular subtypes, and potential drugs in allergic rhinitis based on an inflammatory response gene set
by: Jun Dai, et al.
Published: (2024-02-01)

Preoperative systemic inflammation response index is an independent prognostic marker for BCG immunotherapy in patients with non‐muscle‐invasive bladder cancer
by: Kun Ye, et al.
Published: (2023-02-01)

Construction and Verification of the Molecular Subtype and a Novel Prognostic Signature Based on Inflammatory Response-Related Genes in Uveal Melanoma
by: Feng Zhang, et al.
Published: (2023-01-01)

A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma
by: Wenhao Ouyang, et al.
Published: (2022-01-01)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
by: Chong Li, et al.
Published: (2023-06-01)

Role of platelet biomarkers in inflammatory response
by: Yufei Chen, et al.
Published: (2020-08-01)

Editorial: Community series in novel biomarkers for predicting response to cancer immunotherapy: volume II
by: Keyong Peng, et al.
Published: (2023-12-01)

Lipidomics signature in post-COVID patient sera and its influence on the prolonged inflammatory response
by: P.F. Garrido, et al.
Published: (2024-04-01)

Preoperative systemic inflammatory response index predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation
by: Songping Cui, et al.
Published: (2023-03-01)

The Role of the Immune Response in Brain Metastases: Novel Imaging Biomarkers for Immunotherapy
by: Rasheed Zakaria, et al.
Published: (2021-10-01)

Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma
by: Xin Zhang, et al.
Published: (2023-03-01)

Imaging Assessment of Tumor Response in the Era of Immunotherapy
by: Jun Nakata, et al.
Published: (2021-06-01)

An Inflammatory Response-Related Gene Signature Reveals Distinct Survival Outcome and Tumor Microenvironment Characterization in Pancreatic Cancer
by: Fengxiao Xie, et al.
Published: (2022-06-01)

An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer
by: Kaibo Zhu, et al.
Published: (2024-01-01)

Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
by: Zewei Tu, et al.
Published: (2023-02-01)

Deciphering Differential Behavior of Immune Responses as the Foundation for Precision Dosing in Allergen Immunotherapy
by: Antoine Magnan, et al.
Published: (2023-02-01)

Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response
by: Jiani Wu, et al.
Published: (2021-09-01)

Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data
by: Chong Shen, et al.
Published: (2023-06-01)